BeiGene’s Tislelizumab Delivers With OS Data In Broad Gastric Cancer Population

 
• By Jessica Merrill
  
applause
Tislelizumab improved overall survival in gastric cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category